Figure 11.
The correlation between CDKN2A expression and the prognosis of PCa in disease-free survival (P < .01). CDKN2A = cyclin-dependent kinase inhibitor 2A, PCa = prostate cancer.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.